Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma
Clinical trial NCT00539591 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00539591
- Sponsor
- St. Jude Children's Research Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-09
- Primary completion
- 2015-06-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.